Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top
Stocks & Markets Analysis
Views 3.3M Contents 5433

This explains the spike.

$Arbutus Biopharma (ABUS.US)$ won a lawsuit over a patent pertaining to the COVID-19 vaccine. The patent is essential, so if $Moderna (MRNA.US)$ wants to "lead the charge," they have a big speed bump here. With that said, it would be nothing for MRNA to buy out ABUS, especially before shares run up.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
5
See Original
Report
56K Views
Comment
Sign in to post a comment
avatar
Video Sharer
Interests: Community strength & growing awareness, average people accumulating truth, knowledge & wisdom in the Markets
15KFollowers
1282Following
11KVisitors
Follow